1. Home
  2. WAFD vs NUVB Comparison

WAFD vs NUVB Comparison

Compare WAFD & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc.

WAFD

WaFd Inc.

HOLD

Current Price

$33.31

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.51

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFD
NUVB
Founded
1917
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WAFD
NUVB
Price
$33.31
$8.51
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$31.40
$10.63
AVG Volume (30 Days)
834.0K
10.3M
Earning Date
01-15-2026
11-03-2025
Dividend Yield
3.28%
N/A
EPS Growth
5.31
N/A
EPS
2.63
N/A
Revenue
$717,732,000.00
$26,748,000.00
Revenue This Year
$8.66
$609.55
Revenue Next Year
$4.77
$197.91
P/E Ratio
$12.51
N/A
Revenue Growth
1.95
1137.19
52 Week Low
$23.75
$1.54
52 Week High
$36.41
$8.95

Technical Indicators

Market Signals
Indicator
WAFD
NUVB
Relative Strength Index (RSI) 66.87 68.68
Support Level $32.70 $7.80
Resistance Level $33.65 $8.95
Average True Range (ATR) 0.68 0.50
MACD 0.07 -0.05
Stochastic Oscillator 79.82 70.76

Price Performance

Historical Comparison
WAFD
NUVB

About WAFD WaFd Inc.

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: